BioSpace News Archive

Directed share issue strengthens the cash position ahead of the CONDUCT results

Funding to advance clinical trials of Inflazome’s pioneering orally-available NLRP3 inflammasome inhibitor compounds in several chronic inflammatory diseases

Swedish Orphan Biovitrum AB has appointed Paula Treutiger as Head of Communications and Investor Relations. Paula will join Sobi on 1 January 2019 and be part of Sobi’s Executive Committee.

Pet specialty retailer supports commitment to total pet care and wellness with convenient, accessible pet prescriptions available online for doorstep delivery

DaVita Kidney Care releases ‘Holiday Gatherings’ Cookbook

BiondVax is a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate.

Decision may help more patients access RTI’s SImmetry® Sacroiliac Joint Fusion System, a minimally invasive surgical solution for sacroiliac (SI) joint dysfunction

uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the expansion of its research pipeline with novel AAV gene therapy approaches to treating Hemophilia A, Fabry disease and Spinocerebellar Ataxia Type 3 at the Company’s Research & Development Day held this morning in New York City.